Adrienne A. Phillips, MD, MPH, shares results seen with mogamulizumab in the largest randomized clinical trial of relapsed/refractory T-cell leukemia to date.
Skip Nav Destination
Mogamulizumab May Be Effective in Relapsed/Refractory T-Cell Leukemia
December 30, 2021
Content License:Private